Using a signature of REDD1 loss was required, as tumor cell levels of REDD1 itself in bulk RNA-seq data are confounded by substantially higher expression in nonepithelial than epithelial cells (Supplemental Fig. S6A). The gene discussed is DDIT4; the disease is neoplasm.